Serum midkine levels are increased in patients with various types of carcinomas

Abstract

The level of expression of midkine (MK), a heparin-binding growth factor, is increased in many types of human carcinomas. An enzyme-linked immunoassay, which utilizes a combination of rabbit and chicken antibodies revealed that serum MK level in the controls (n = 135) was 0.154 +/- 0.076 (mean +/- SD) ng ml(-1)with an apparent cut-off value as 0.5 ng ml(-1). Serum MK level was significantly elevated in the cancer patients (n = 150) (P< 0.001); 87% of the patients showed levels of more than 0.5 ng ml(-1). All ten types of cancer examined showed a similar profile of serum MK level. There was no or weak correlation between C-reactive protein level, a marker of inflammation, and serum MK level. Furthermore, in case of gastric carcinoma and lung carcinoma, patients with stage I carcinoma already showed elevated serum MK levels. The present results indicated that serum MK could serve as a general tumour marker with a good potential for clinical application.

References 25

1. 1.

   Aridome K., Tsutsui J., Takao S., Kadomatsu K., Ozawa M., Aikou T., Muramatsu T. Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res. 1995;86(7):655-661.

   Not in our library10.1111/j.1349-7006.1995.tb02449.x

2. 2.

   Choudhuri R., Zhang H. T., Donnini S., Ziche M., Bicknell R. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res. 1997;57(9):1814-1819.

   Not in our library

3. 3.

   Garver R. I., Radford D. M., Donis-Keller H., Wick M. R., Milner P. G. Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer. 1994;74(5):1584-1590.

   Not in our library10.1002/1097-0142(19940901)74:5<1584::aid-cncr2820740514>3.0.co;2-v

4. 4.

   Horiba M., Kadomatsu K., Nakamura E., Muramatsu H., Ikematsu S., Sakuma S., Hayashi K., Yuzawa Y., Matsuo S., Kuzuya M. Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest. 2000;105(4):489-495.

   Not in our library10.1172/jci7208

5. 5.

   Ishikawa E., Yoshitake S., Imagawa M., Sumiyoshi A. Preparation of monomeric Fab'-horseradish peroxidase conjugate using thiol groups in the hinge and its evaluation in enzyme immunoassay and immunohistochemical staining. Ann N Y Acad Sci. 1983;420:74-89.

   Not in our library10.1111/j.1749-6632.1983.tb22191.x

6. 6.
   Midkine induces the transformation of NIH3T3 cells · 1997

   No notice
7. 7.

   Kadomatsu K., Tomomura M., Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun. 1988;151(3):1312-1318.

   Not in our library10.1016/s0006-291x(88)80505-9

8. 8.

   Kojima S., Muramatsu H., Amanuma H., Muramatsu T. Midkine enhances fibrinolytic activity of bovine endothelial cells. J Biol Chem. 1995;270(16):9590-9596.

   Not in our library10.1074/jbc.270.16.9590

9. 9.

   Konishi N., Nakamura M., Nakaoka S., Hiasa Y., Cho M., Uemura H., Hirao Y., Muramatsu T., Kadomatsu K. Immunohistochemical analysis of midkine expression in human prostate carcinoma. Oncology. 1999;57(3):253-257.

   Not in our library10.1159/000012039

10. 10.

    Kurtz A., Schulte A. M., Wellstein A. Pleiotrophin and midkine in normal development and tumor biology. Crit Rev Oncog. 1995;6(2):151-177.

    Not in our library

11. 11.

    Li Y. S., Milner P. G., Chauhan A. K., Watson M. A., Hoffman R. M., Kodner C. M., Milbrandt J., Deuel T. F. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science. 1990;250(4988):1690-1694.

    Not in our library10.1126/science.2270483

12. 12.

    Maeda N., Ichihara-Tanaka K., Kimura T., Kadomatsu K., Muramatsu T., Noda M. A receptor-like protein-tyrosine phosphatase PTPzeta/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta. J Biol Chem. 1999;274(18):12474-12479.

    Not in our library10.1074/jbc.274.18.12474

13. 13.

    Merenmies J., Rauvala H. Molecular cloning of the 18-kDa growth-associated protein of developing brain. J Biol Chem. 1990;265(28):16721-16724.

    Not in our library

14. 14.

    Michikawa M., Kikuchi S., Muramatsu H., Muramatsu T., Kim S. U. Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. J Neurosci Res. 1993;35(5):530-539.

    Not in our library10.1002/jnr.490350509

15. 15.

    Mishima K., Asai A., Kadomatsu K., Ino Y., Nomura K., Narita Y., Muramatsu T., Kirino T. Increased expression of midkine during the progression of human astrocytomas. Neurosci Lett. 1997;233(1):29-32.

    Not in our library10.1016/s0304-3940(97)00619-8

16. 16.

    Muramatsu H., Shirahama H., Yonezawa S., Maruta H., Muramatsu T. Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev Biol. 1993;159(2):392-402.

    Not in our library10.1006/dbio.1993.1250

17. 17.

    Muramatsu H., Song X. J., Koide N., Hada H., Tsuji T., Kadomatsu K., Inui T., Kimura T., Sakakibara S., Muramatsu T. Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas. J Biochem. 1996;119(6):1171-1175.

    Not in our library10.1093/oxfordjournals.jbchem.a021364

18. 18.

    Nakagawara A., Milbrandt J., Muramatsu T., Deuel T. F., Zhao H., Cnaan A., Brodeur G. M. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res. 1995;55(8):1792-1797.

    Not in our library

19. 19.

    O'Brien T., Cranston D., Fuggle S., Bicknell R., Harris A. L. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res. 1996;56(11):2515-2518.

    Not in our library

20. 20.

    Owada K., Sanjo N., Kobayashi T., Mizusawa H., Muramatsu H., Muramatsu T., Michikawa M. Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J Neurochem. 1999;73(5):2084-2092.

    Not in our library

21. 21.

    Qi M., Ikematsu S., Ichihara-Tanaka K., Sakuma S., Muramatsu T., Kadomatsu K. Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by Midkine. J Biochem. 2000;127(2):269-277.

    Not in our library10.1093/oxfordjournals.jbchem.a022604

22. 22.

    Raulais D., Lagente-Chevallier O., Guettet C., Duprez D., Courtois Y., Vigny M. A new heparin binding protein regulated by retinoic acid from chick embryo. Biochem Biophys Res Commun. 1991;174(2):708-715.

    Not in our library10.1016/0006-291x(91)91475-r

23. 23.

    Takada T., Toriyama K., Muramatsu H., Song X. J., Torii S., Muramatsu T. Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J Biochem. 1997;122(2):453-458.

    Not in our library10.1093/oxfordjournals.jbchem.a021773

24. 24.

    Tsutsui J., Kadomatsu K., Matsubara S., Nakagawara A., Hamanoue M., Takao S., Shimazu H., Ohi Y., Muramatsu T. A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res. 1993;53(6):1281-1285.

    Not in our library

25. 25.

    Ye C., Qi M., Fan Q. W., Ito K., Akiyama S., Kasai Y., Matsuyama M., Muramatsu T., Kadomatsu K. Expression of midkine in the early stage of carcinogenesis in human colorectal cancer. Br J Cancer. 1999;79(1):179-184.

    Not in our library10.1038/sj.bjc.6690030

Cited by papers we hold 1

• A list of candidate cancer biomarkers for targeted proteomics. · 2007
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.